Evolution of the volume-outcome relation for hospitals performing coronary angioplasty

V Ho1

  • 1John M. Olin School of Business, Washington University, St Louis, MO 63130-4899, USA. ho@olin.wustl.edu

Circulation
|April 19, 2000
PubMed

Insights

Hospital procedure volume impacts patient outcomes. This study shows outcomes improved for all hospitals over time, narrowing the gap between low- and high-volume centers for percutaneous transluminal coronary angioplasty (PTCA).

Area of Science:

  • Cardiovascular Surgery
  • Health Services Research
  • Medical Quality Improvement

Background:

  • Higher surgical procedure volumes in hospitals are generally associated with better patient outcomes.
  • This study investigates the historical trends of the volume-outcome relationship in healthcare.

Purpose of the Study:

  • To examine the evolution of the volume-outcome relationship for percutaneous transluminal coronary angioplasty (PTCA) procedures over time.
  • To assess changes in in-hospital mortality and bypass surgery rates based on hospital PTCA volume across different time periods.

Main Methods:

  • Analysis of 353,488 patient cases treated in California between 1984 and 1996.
  • Utilized descriptive statistics and logistic regression to compare outcomes across three distinct time intervals: 1984-1987, 1988-1992, and 1993-1996.
  • Examined in-hospital mortality and bypass surgery rates in relation to hospital PTCA procedure volume (<200 vs. >400 procedures/year).

Main Results:

  • In-hospital mortality for low-volume (<200 PTCA/year) vs. high-volume (>400 PTCA/year) hospitals decreased from 2.5% vs. 1.3% (1984-1987) to 1.7% vs. 1.3% (1993-1996).
  • Bypass surgery rates narrowed and decreased in low-volume vs. high-volume hospitals, from 12.4% vs. 6.9% to 4.6% vs. 3.3% over the study period.
  • PTCA volume significantly predicted mortality and bypass rates, with outcome improvements in low-volume hospitals comparable to benefits seen in high-volume centers.

Conclusions:

  • The disparity in outcomes between low- and high-volume hospitals for PTCA has significantly narrowed over time.
  • All hospitals demonstrated substantial improvements in patient outcomes, irrespective of initial volume.
  • Lower minimum volume standards for PTCA may be appropriate in underserved areas where angioplasty is otherwise unavailable.
Abstract

Related Concept Videos

Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac output averages...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...